TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8770129

Group type: EXPERIMENTAL
Intervention: Pupil diameter measurements
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Palpebral fissure measurements
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall study findings
Number of subjects: 24
Study: 1579323

Group type: EXPERIMENTAL
Intervention: Cyclic treatment with 2 mg of estradiol valerate for 3 weeks + 250 micrograms of levonorgestrel for the last 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20-micrograms/24-hour levonorgestrel-releasing intrauterine device (IUD) + 2 mg of estradiol valerate daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Cyclic treatment and IUD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: IUD group
Number of subjects: 40
Study: 4044854

Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Video game training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both groups combined (Biofeedback and Video game)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-treatment controls (Institutionalized residents)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-treatment controls (Staff counselors)
Number of subjects: 12
Study: 3553048

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 0
Study: 31854463

Group type: EXPERIMENTAL
Intervention: Shoulder block (20 ml bupivacaine 0.5%)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Shoulder block
Number of subjects: 30

Group type: COMPARATOR
Intervention: Interscalene block (20 ml bupivacaine 0.5%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Interscalene block
Number of subjects: 30
Study: 29921529

Group type: EXPERIMENTAL
Intervention: 1.5 mA left-DLPFC anodal tDCS
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Left-DLPFC cathodal tDCS
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 22
Study: 26804105

Group type: EXPERIMENTAL
Intervention: Web-based employability intervention
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 26065432

Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (2 mA, 35 cm², for 20 minutes, 5 sessions)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham-transcranial direct current stimulation (placebo)
Number of subjects: 17
Study: 24355241

Group type: EXPERIMENTAL
Intervention: Intranasal administration of hyaluronic acid (HA) using Ialumar® nasal spray for 30 days
Number of subjects: 59

Group type: COMPARATOR
Intervention: Physiological solution (control group) for 30 days
Number of subjects: 59
Study: 21914589

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) adjunctive therapy, dosage of 244.8 ± 108 mg/d at study end
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) adjunctive therapy
Number of subjects: 207
Study: 18946826

Group type: EXPERIMENTAL
Intervention: Computer-based animations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static graphics
Number of subjects: 0
Study: 17219526

Group type: EXPERIMENTAL
Intervention: Standard education plus the educational intervention (two small-group, case-based discussions on acute dyspnea management)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard education (control group)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Standard education plus the educational intervention (per-protocol analysis)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Standard education plus the educational intervention
Number of subjects: 26
Study: 14607015

Group type: EXPERIMENTAL
Intervention: Conventional paracetamol tablets (1,500 mg) with morphine (10 mg 4 hourly for 12 hours prior)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conventional paracetamol tablets (1,500 mg) without morphine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Dispersible paracetamol tablets (1,500 mg) with morphine (10 mg 4 hourly for 12 hours prior)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Dispersible paracetamol tablets (1,500 mg) without morphine
Number of subjects: 2
Study: 11004039

Group type: EXPERIMENTAL
Intervention: 1% hypobaric lidocaine 50 mg (Group L50)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 1% hypobaric lidocaine 20 mg + 25 microg fentanyl (Group L20/F25)
Number of subjects: 110
Study: 8625683

Group type: EXPERIMENTAL
Intervention: i.v. milrinone lactate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1475810

Group type: EXPERIMENTAL
Intervention: Malaria chemoprophylaxis during pregnancy
Number of subjects: 0
Study: 6364997

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 30
Study: 31733786

Group type: EXPERIMENTAL
Intervention: Treadmill gait training together with traditional treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 20
Study: 29967446

Group type: EXPERIMENTAL
Intervention: Focal individuals synchronised with their closest neighbour
Number of subjects: 0

Group type: COMPARATOR
Intervention: Focal individuals not synchronised with their closest neighbour
Number of subjects: 0
Study: 27495291

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glimepiride (6-8 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Canagliflozin (100 mg and 300 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 0
Study: 25064721

Group type: EXPERIMENTAL
Intervention: BBFC (brinzolamide 1% and brimonidine 0.2%)
Number of subjects: 560

Group type: COMPARATOR
Intervention: brinzolamide 1%
Number of subjects: 560

Group type: COMPARATOR
Intervention: brimonidine 0.2%
Number of subjects: 560
Study: 22377820

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition
Number of subjects: 154

Group type: COMPARATOR
Intervention: Parenteral nutrition
Number of subjects: 154
Study: 20132586

Group type: EXPERIMENTAL
Intervention: Oil diet (mean beta-carotene intake 3.1 mg/d)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Mixed diet (mean beta-carotene intake 7.6 mg/d)
Number of subjects: 17
Study: 17714824

Group type: EXPERIMENTAL
Intervention: Repaglinide/Metformin/NPH (Group A)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Metformin/NPH (Group B)
Number of subjects: 37

Group type: COMPARATOR
Intervention: NPH/NPH (Group C)
Number of subjects: 37
Study: 15877556

Group type: EXPERIMENTAL
Intervention: Interdisciplinary program of geriatric consultation, continuous rehabilitation, and discharge planning
Number of subjects: 137
Study: 11967679

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg intravenous before extubation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study: 9579009

Group type: EXPERIMENTAL
Intervention: Low-intensity, healthy-weight intervention (18 pamphlets mailed over 8 weeks)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 188
Study: 8617529

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no vitamin A supplementation)
Number of subjects: 108
Study: 2750831

Group type: EXPERIMENTAL
Intervention: Cryotherapy and episcleral sponges
Number of subjects: 175

Group type: COMPARATOR
Intervention: Diathermy, scleral dissection, and encircling silicone bands
Number of subjects: 175
Study: 371319

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotic bowel preparation for 24 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotic bowel preparation for 60 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative antibiotic bowel preparation (both 24 and 60 hours)
Number of subjects: 0
Study: 31609189

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics (SGAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-acting injection formulations of SGAs
Number of subjects: 0
Study: 31302964

Group type: EXPERIMENTAL
Intervention: CA-TAMIS-GP
Number of subjects: 67

Group type: COMPARATOR
Intervention: ESD
Number of subjects: 67
Study: 30400965

Group type: EXPERIMENTAL
Intervention: Opioid replacement therapy
Number of subjects: 148

Group type: COMPARATOR
Intervention: General opioid dependent patients using substance use disorder services
Number of subjects: 148
Study: 28107141

Group type: EXPERIMENTAL
Intervention: Surgery by conventional means (group B)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Surgery with microdebrider (group C)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Nonsurgically treated (group A)
Number of subjects: 151
Study: 24029470

Group type: EXPERIMENTAL
Intervention: Auto-servo ventilation (ASV)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Optimal medical treatment (control)
Number of subjects: 32
Study: 22681932

Group type: EXPERIMENTAL
Intervention: Standardised O&M-training
Number of subjects: 68

Group type: COMPARATOR
Intervention: Regular O&M-training
Number of subjects: 68
Study: 19101663

Group type: EXPERIMENTAL
Intervention: Notebook computer accessories
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Notebook computer accessories and participatory ergonomics training
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Post-survey rest breaks
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Self-reported computer usage
Number of subjects: 289
Study: 17484179

Group type: EXPERIMENTAL
Intervention: DCR
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Song's polyurethane stent
Number of subjects: 28
Study: 15305249

Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg/mL
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ropivacaine 5 mg/mL
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ropivacaine 3.75 mg/mL
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 93
Study: 12191848

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 50 microg daily for 12 months
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Transdermal norethisterone acetate (NETA) continuously (170 or 350 microg/day)
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Sequential oral NETA (1 mg/day)
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Dydrogesterone (20 mg/day)
Number of subjects: 567

Group type: COMPARATOR
Intervention: British women
Number of subjects: 567
Study: 9389846

Group type: EXPERIMENTAL
Intervention: Pressure Controlled Ventilation (PCV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Volume Controlled Ventilation (VCV)
Number of subjects: 48
Study: 7946856

Group type: EXPERIMENTAL
Intervention: Adrenaline (group 1, n = 11)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hydrocortisone and adrenaline (group 2, n = 11)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neither hydrocortisone nor adrenaline (group 3, n = 8)
Number of subjects: 30
Study: 3428285

Group type: EXPERIMENTAL
Intervention: Carbimazole pretreatment for a minimum of three months before 131I therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: 131I therapy alone
Number of subjects: 24
Study: 29605187

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Antipsychotics
Number of subjects: 75
Study: 29121294

Group type: EXPERIMENTAL
Intervention: Buprenorphine i.v. infusion (25 μg h ‐1 for 24 h)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Morphine (equianalgesic dose)
Number of subjects: 64
Study: 25637938

Group type: COMPARATOR
Intervention: bupivacaine, 0.25% 30 mL
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: bupivacaine, 0.25% 30 mL with 1‐mg dexamethasone
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: bupivacaine, 0.25% 30 mL with 2‐mg dexamethasone
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: bupivacaine, 0.25% 30 mL with 4‐mg dexamethasone
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: dexamethasone (all doses)
Number of subjects: 89
Study: 23618502

Group type: EXPERIMENTAL
Intervention: 3 months neo-adjuvant androgen suppression (NAS) before radiotherapy (RT)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: 6 months neo-adjuvant androgen suppression (NAS) before radiotherapy (RT)
Number of subjects: 802

Group type: COMPARATOR
Intervention: 0 months neo-adjuvant androgen suppression (NAS) before radiotherapy (RT)
Number of subjects: 802
Study: 21413116

Group type: EXPERIMENTAL
Intervention: Paclitaxel coated balloon + endothelial progenitor capture stent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug eluting stent (DES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endothelial progenitor capture stent
Number of subjects: 0
Study: 18296973

Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tennis-specific Drills Training (TDT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combined Training (CT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 64
Study: 16458131

Group type: EXPERIMENTAL
Intervention: Upstream use of small molecule GP IIb/IIIa inhibitors for all ACS patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective use of abciximab only in patients requiring PCI
Number of subjects: 0
Study: 12758236

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus mitomycin C (MMC) (15 mg/m² single injection at the end of the first week of radiotherapy)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 478

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus mitomycin C (MMC)
Number of subjects: 478
Study: 10739392

Group type: EXPERIMENTAL
Intervention: 50 mg aspirin/day p.o. for 11 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin/day p.o. for 11 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: 100 mg L-aspirin infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both doses of aspirin
Number of subjects: 10
Study: 9214283

Group type: EXPERIMENTAL
Intervention: bifacid
Number of subjects: 60

Group type: COMPARATOR
Intervention: bifidumbacterin
Number of subjects: 60
Study: 8157945

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg for the first month, 20 mg for the second month, 40 mg for the remaining 4 months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 3063660

Group type: EXPERIMENTAL
Intervention: Penfluridol, administered once weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trifluoperazine, administered twice daily
Number of subjects: 0
Study: 29624540

Group type: EXPERIMENTAL
Intervention: Auditory Steady State Response (ASSR)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Auditory Brainstem Response (ABR)
Number of subjects: 102
Study: 28120856

Group type: EXPERIMENTAL
Intervention: l-arginine supplementation (2 g per day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 56
Study: 24589310

Group type: EXPERIMENTAL
Intervention: Standard dose MDCT
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Ultra-low dose MDCT
Number of subjects: 1000
Study: 22592040

Group type: EXPERIMENTAL
Intervention: Progressive compressive stockings (10 mm Hg at ankle, 23 mm Hg at upper calf)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Degressive compressive stockings (30 mm Hg at ankle, 21 mm Hg at upper calf)
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Progressive compressive stockings
Number of subjects: 401

Group type: COMPARATOR
Intervention: Degressive compressive stockings
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 401
Study: 20211294

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily (2.5 mg twice daily in selected patients)
Number of subjects: 5600

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 81 to 324 mg once daily
Number of subjects: 5600
Study: 17966532

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (15 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40
Study: 15298986

Group type: EXPERIMENTAL
Intervention: ULLS plus Resistance Exercise (RE)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE) only
Number of subjects: 31

Group type: COMPARATOR
Intervention: Unilateral Limb Suspension (ULLS)
Number of subjects: 31
Study: 11850750

Group type: EXPERIMENTAL
Intervention: AGB plus surgical removal of the total greater omentum
Number of subjects: 50

Group type: COMPARATOR
Intervention: AGB alone
Number of subjects: 50
Study: 9659857

Group type: EXPERIMENTAL
Intervention: 25 mg/day of olanzapine
Number of subjects: 84

Group type: COMPARATOR
Intervention: 1200 mg/day of chlorpromazine plus 4 mg/day of benztropine mesylate
Number of subjects: 84
Study: 7982430

Group type: EXPERIMENTAL
Intervention: Cibenzoline
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 2500466

Group type: EXPERIMENTAL
Intervention: Extended treatment of 40 weekly sessions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard treatment of 20 weekly sessions
Number of subjects: 48
Study: 31745855

Group type: EXPERIMENTAL
Intervention: cCBT (combined cCBT-only and cCBT+ISG groups)
Number of subjects: 689

Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 689

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 689
Study: 31226526

Group type: EXPERIMENTAL
Intervention: Citric acid/tetracycline gel (CAT) group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: aPDT group
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (SRP)
Number of subjects: 17
Study: 28963921

Group type: EXPERIMENTAL
Intervention: Cultural competence education delivered via Facebook (FB)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Regular educational program (Control Group)
Number of subjects: 180
Study: 25684586

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg orally once daily
Number of subjects: 1945

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1945
Study: 23343391

Group type: EXPERIMENTAL
Intervention: Systematic screening with information and home sampling
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 10000
Study: 21700430

Group type: EXPERIMENTAL
Intervention: Iloperidone 10-16 mg
Number of subjects: 3580

Group type: EXPERIMENTAL
Intervention: Iloperidone 20-24 mg
Number of subjects: 3580

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3580
Study: 18339212

Group type: EXPERIMENTAL
Intervention: HES 130/0.4 (6% hydroxyethyl starch, Voluven)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Human albumin 5%
Number of subjects: 81
Study: 16701187

Group type: EXPERIMENTAL
Intervention: 2 mL bupivacaine plus midazolam 2 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 mL bupivacaine plus midazolam 1 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2 mL hyperbaric bupivacaine 0.5%
Number of subjects: 60
Study: 12921806

Group type: EXPERIMENTAL
Intervention: Post-exercise regional circulatory occlusion (PE-RCO) during arm exercises
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Post-exercise regional circulatory occlusion (PE-RCO) during leg exercises
Number of subjects: 12

Group type: COMPARATOR
Intervention: Passive movement mechanoreflex
Number of subjects: 12

Group type: COMPARATOR
Intervention: Active exercise mechanoreflex
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metaboreflex reproducibility in heart failure patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mechanoreflex reproducibility during passive movement
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mechanoreflex reproducibility during active exercise
Number of subjects: 12
Study: 11092646

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens 0.625 mg (combined with medroxyprogesterone acetate 2.5 mg daily in five women with uterus intact)
Number of subjects: 10
Study: 9126089

Group type: EXPERIMENTAL
Intervention: 20 mg paroxetine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 40 mg paroxetine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (in the 20 mg group)
Number of subjects: 34
Study: 1530172

Group type: EXPERIMENTAL
Intervention: 100 mg of lidocaine + 0.05 mg of fentanyl + 0.5 mg of pancuronium (group D)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 100 mg of lidocaine + 0.05 mg of fentanyl (group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 100 mg of lidocaine + 0.5 mg of pancuronium (group C)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 100 mg of lidocaine (group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 100 mg of lidocaine + 0.05 mg of fentanyl + 0.5 mg of pancuronium (group E) for safety evaluation
Number of subjects: 80
Study: 3924285

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 19

Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 19
Study: 31689326

Group type: EXPERIMENTAL
Intervention: Organised mass prostate-cancer screening based on PSA testing
Number of subjects: 80149

Group type: COMPARATOR
Intervention: Control group (no organised screening)
Number of subjects: 80149
Study: 27627098

Group type: EXPERIMENTAL
Intervention: Anti-TNF-α treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-responder patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRABP-II SNPs analysis
Number of subjects: 0
Study: 27160164

Group type: COMPARATOR
Intervention: Exercise intervention (twice a week for 12 months)
Number of subjects: 194
Study: 24237879

Group type: COMPARATOR
Intervention: Intranasal midazolam (0.2 mg·kg(‐1))
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (1 μg·kg(‐1))
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 22119927

Group type: EXPERIMENTAL
Intervention: Pentavac(®) vaccine manufactured at large scale
Number of subjects: 720

Group type: COMPARATOR
Intervention: Pentavac(®) vaccine manufactured at small scale
Number of subjects: 720
Study: 20580361

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) 20 mg vaginally
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48